Diagnostic Performance of a Combined Rapid Antigen Test for Detecting SARS‐CoV‐2, Influenza Virus, and Respiratory Syncytial Virus in Symptomatic Patients in Tertiary Care

Documenti analoghi

• Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens
  di: Rainer Gosert, et al.
  Pubblicazione: (2024)
• Rebound of Respiratory Virus Activity and Seasonality to Pre‐Pandemic Patterns
  di: Rainer Gosert, et al.
  Pubblicazione: (2025)
• Prevalence of Influenza Viruses A and B, Adenovirus, Respiratory Syncytial Virus, and Human Metapneumonia Viruses among Children with Acute Respiratory Tract Infection
  di: Rana Farzi, et al.
  Pubblicazione: (2024)
• Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France
  di: Cécile Chauvel, et al.
  Pubblicazione: (2025)
• Development and Validation of Amplicon‐Based Protocol for Sequencing of Respiratory Syncytial Virus Genome
  di: Guglielmo Ferrari, et al.
  Pubblicazione: (2025)